Published in Nucleic Acids Res on April 11, 1995
Discovery and development of the G-rich oligonucleotide AS1411 as a novel treatment for cancer. Exp Mol Pathol (2009) 2.25
Formation of a G-tetrad and higher order structures correlates with biological activity of the RelA (NF-kappaB p65) 'antisense' oligodeoxynucleotide. Nucleic Acids Res (1997) 1.01
Multiple mechanisms may contribute to the cellular anti-adhesive effects of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res (1996) 0.91
Temperature and salt dependence of higher order structure formation by antisense c-myc and c-myb phosphorothioate oligodeoxyribonucleotides containing tetraguanylate tracts. Nucleic Acids Res (1997) 0.83
Antisense treatment directed against mutated Ki-ras in human colorectal adenocarcinoma. Gut (2001) 0.80
An inducible transcription factor activates expression of human immunodeficiency virus in T cells. Nature (1987) 19.23
NF-kappa B and Rel: participants in a multiform transcriptional regulatory system. Int Rev Cytol (1993) 7.42
DNA binding and I kappa B inhibition of the cloned p65 subunit of NF-kappa B, a rel-related polypeptide. Cell (1991) 6.63
Specific regulation of gene expression by antisense, sense and antigene nucleic acids. Biochim Biophys Acta (1990) 5.55
Isolation of a rel-related human cDNA that potentially encodes the 65-kD subunit of NF-kappa B. Science (1991) 5.52
Antisense oligonucleotides as therapeutic agents--is the bullet really magical? Science (1993) 5.50
A cooperative interaction between NF-kappa B and Sp1 is required for HIV-1 enhancer activation. EMBO J (1993) 3.74
Gene inhibition using antisense oligodeoxynucleotides. Nature (1994) 3.26
Antisense c-myb oligonucleotides inhibit intimal arterial smooth muscle cell accumulation in vivo. Nature (1992) 2.73
An interaction between the DNA-binding domains of RelA(p65) and Sp1 mediates human immunodeficiency virus gene activation. Mol Cell Biol (1994) 2.26
Cloning of the human gene for intercellular adhesion molecule 1 and analysis of its 5'-regulatory region. Induction by cytokines and phorbol ester. J Immunol (1991) 2.09
Specificity of antisense oligonucleotides in vivo. Proc Natl Acad Sci U S A (1992) 2.00
An NF kappa B-like factor is essential but not sufficient for cytokine induction of endothelial leukocyte adhesion molecule 1 (ELAM-1) gene transcription. Nucleic Acids Res (1991) 1.94
Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression. Proc Natl Acad Sci U S A (1993) 1.86
Ablation of transplanted HTLV-I Tax-transformed tumors in mice by antisense inhibition of NF-kappa B. Science (1992) 1.85
Effect of phosphorothioate modification of oligodeoxynucleotides on specific protein binding. J Biol Chem (1994) 1.76
Effect of human T-cell leukemia virus type I tax protein on activation of the human vimentin gene. J Virol (1990) 1.64
Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial. Antisense Res Dev (1993) 1.61
Evidence for differential functions of the p50 and p65 subunits of NF-kappa B with a cell adhesion model. Mol Cell Biol (1993) 1.54
Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides. Antisense Res Dev (1994) 1.27
Fibronectin attachment activates the NF-kappa B p50/p65 heterodimer in fibroblasts and smooth muscle cells. J Biol Chem (1994) 1.25
Antisense RNA to the putative tumor-suppressor gene DCC transforms Rat-1 fibroblasts. Oncogene (1992) 1.22
Antisense oligonucleotides to the p65 subunit of NF-kappa B block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes. Blood (1993) 1.21
Effects of sequence of thioated oligonucleotides on cultured human mammary epithelial cells. Antisense Res Dev (1993) 1.14
Inhibition of phorbol ester-induced cellular adhesion by competitive binding of NF-kappa B in vivo. Mol Cell Biol (1993) 1.03
Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides. Proc Natl Acad Sci U S A (1994) 0.96
Regulation of adhesion and growth of fibrosarcoma cells by NF-kappa B RelA involves transforming growth factor beta. Mol Cell Biol (1994) 0.88
A sense phosphorothioate oligonucleotide directed to the initiation codon of transcription factor NF-kappa B p65 causes sequence-specific immune stimulation. Antisense Res Dev (1993) 0.87
Antisense oligodeoxynucleotides. Curr Opin Oncol (1994) 0.86
Aptameric inhibition of p210bcr-abl tyrosine kinase autophosphorylation by oligodeoxynucleotides of defined sequence and backbone structure. Nucleic Acids Res (1994) 0.85
Chimeric oligodeoxynucleotide analogues: enhanced cell uptake of structures which direct ribonuclease H with high specificity. Anticancer Drug Des (1993) 0.83
Antisense therapy of cancer. In Vivo (1995) 0.80
Sunburn and p53 in the onset of skin cancer. Nature (1995) 5.35
Mutation hotspots due to sunlight in the p53 gene of nonmelanoma skin cancers. Proc Natl Acad Sci U S A (1993) 2.89
Functional characterization of the NF-kappa B p65 transcriptional activator and an alternatively spliced derivative. Mol Cell Biol (1992) 2.67
Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression. Proc Natl Acad Sci U S A (1993) 1.86
Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS. Science (1984) 1.73
Thiol agents and Bcl-2 identify an alphavirus-induced apoptotic pathway that requires activation of the transcription factor NF-kappa B. J Cell Biol (1995) 1.62
Expression profile of the putative catalytic subunit of the telomerase gene. Cancer Res (1998) 1.57
Placental transfer of paracetamol. J Indian Med Assoc (1989) 1.53
Nucleoside diphosphate kinase, a source of GTP, is required for dynamin-dependent synaptic vesicle recycling. Neuron (2001) 1.46
Synaptic localization and restricted diffusion of a Drosophila neuronal synaptobrevin--green fluorescent protein chimera in vivo. J Neurogenet (2000) 1.42
Cell cycle-dependent modulation of telomerase activity in tumor cells. Proc Natl Acad Sci U S A (1996) 1.42
Differentiation of immortal cells inhibits telomerase activity. Proc Natl Acad Sci U S A (1995) 1.36
Differential roles of stromal cells, interleukin-7, and kit-ligand in the regulation of B lymphopoiesis. Blood (1992) 1.32
Insulin-like growth factor-I regulates pro-B cell differentiation. Blood (1992) 1.29
Cancer gene discovery using digital differential display. Cancer Res (2000) 1.27
Antisense oligonucleotides to the p65 subunit of NF-kappa B block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes. Blood (1993) 1.21
Isolation of a DNA fraction from Ehrlich ascites tumour cells containing the putative origin of replication. J Mol Biol (1982) 1.18
Surface modification of titanium and titanium alloys by ion implantation. J Biomed Mater Res B Appl Biomater (2010) 1.04
Status of kappa L chain gene rearrangements and c-kit and IL-7 receptor expression in stromal cell-dependent pre-B cells. J Immunol (1992) 1.02
Transcriptional inhibition of the inducible nitric oxide synthase gene by competitive binding of NF-kappa B/Rel proteins. Biochem Biophys Res Commun (1995) 1.02
Relevant genomics of neurotensin receptor in cancer. Anticancer Res (2000) 1.01
Incidence of postoperative venous thromboembolism in South India. Br J Surg (1980) 1.01
Telomerase activity in normal human endothelial cells. Anticancer Res (1997) 0.99
The NF-kappaB transcription factor in oncogenesis. Anticancer Res (1996) 0.98
In vivo toxicological effects of rel A antisense phosphorothioates in CD-1 mice. Antisense Res Dev (1994) 0.97
Sterilisation camps in India. Lancet (1990) 0.96
Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides. Proc Natl Acad Sci U S A (1994) 0.96
Nucleosome segregation in chromatin replicated in the presence of cycloheximide. J Mol Biol (1982) 0.95
Microarray-based expression profiling in prostate tumors. In Vivo (2000) 0.95
Nerve growth factor-induced differentiation in PC-12 cells is blocked by fos oncogene. Oncogene (1989) 0.95
Isolation and characterization of a human T cell leukemia virus type II from a hemophilia-A patient with pancytopenia. EMBO J (1985) 0.95
Persistent expression of the tumor suppressor gene DCC is essential for neuronal differentiation. Cell Growth Differ (1992) 0.94
Transcription factor decoy approach to decipher the role of NF-kappa B in oncogenesis. Anticancer Res (1996) 0.93
Connexin43 suppresses MFG-E8 while inducing contact growth inhibition of glioma cells. Cancer Res (2000) 0.92
NF-kappa B as a central mediator in the induction of TGF-beta in monocytes from patients with idiopathic myelofibrosis: an inflammatory response beyond the realm of homeostasis. J Immunol (2000) 0.92
Hydroxyurea treatment does not prevent initiation of DNA synthesis in Ehrlich ascites tumour cells and leads to the accumulation of short DNA fragments containing the replication origins. Biochim Biophys Acta (1984) 0.92
EVALUATION OF WOUND HEALING ACTIVITY OF FLAVONOIDS FROM IPOMOEA CARNEA Jacq. Anc Sci Life (2007) 0.92
Multiple mechanisms may contribute to the cellular anti-adhesive effects of phosphorothioate oligodeoxynucleotides. Nucleic Acids Res (1996) 0.91
In vivo expression of a nonselected gene transferred into murine hematopoietic stem cells by electroporation. Biochem Biophys Res Commun (1986) 0.91
Regulation of adhesion and growth of fibrosarcoma cells by NF-kappa B RelA involves transforming growth factor beta. Mol Cell Biol (1994) 0.88
Rapid diagnosis of leptospirosis in patients with different clinical manifestations by 16S rRNA gene based nested PCR. Saudi J Biol Sci (2011) 0.88
Telomeres, telomerase and cancer: is the magic bullet real? Anticancer Res (1996) 0.87
A sense phosphorothioate oligonucleotide directed to the initiation codon of transcription factor NF-kappa B p65 causes sequence-specific immune stimulation. Antisense Res Dev (1993) 0.87
DNA-mediated gene transfer into epidermal cells using electroporation. Biochem Biophys Res Commun (1986) 0.86
The therapeutic potential of antisense oligonucleotides. Bioessays (1995) 0.86
Antisense oligodeoxynucleotides. Curr Opin Oncol (1994) 0.86
Regulatory cells and cytokines involved in primary B lymphocyte production. Adv Exp Med Biol (1992) 0.86
Aluminium phosphide: worse than Bhopal. Lancet (1988) 0.86
Transcriptional regulation of early growth response genes in FOS-expressing PC-12 cells. Cell Regul (1990) 0.85
Leptospirosis laboratory, Madras Medical College: review of our experience (2004-2006). Indian J Med Microbiol (2008) 0.85
Transcriptional activation of the c-myc proto-oncogene in murine keratinocytes enhances the response to epidermal growth factor. J Invest Dermatol (1989) 0.85
Erythrocyte and plasma cholinesterase activity in normal pregnancy. Indian J Physiol Pharmacol (1990) 0.85
Coordinated expression of intermediate biomarkers for tumorigenic transformation in RAS-transfected mouse mammary epithelial cells. Breast Cancer Res Treat (1991) 0.83
Introduction of deoxyribonucleoside triphosphates into intact cells by electroporation. Anal Biochem (1986) 0.83
Suicide induced by cytolytic activity controls the differentiation of memory CD8(+) T lymphocytes. Int Immunol (2001) 0.82
Characterization of human telomerase complex. Proc Natl Acad Sci U S A (1997) 0.82
Inhibition of PC-12 cell differentiation by the immediate early gene fra-1. Oncogene (1990) 0.81
Neoplastic transformation of mouse mammary epithelial cells by deregulated myc expression. Cell Regul (1990) 0.81
Antisense RNA to the putative tumor suppressor gene "deleted in colorectal cancer" transforms fibroblasts. Ann N Y Acad Sci (1992) 0.81
A DNA motif present in alpha V integrin promoter exhibits dual binding preference to distinct transcription factors. Anticancer Res (1996) 0.80
The value of DNA paternity identification in beef cattle: examples from Nevada's free-range ranches. J Anim Sci (2007) 0.80
Increased quinolinate immunoreactivity in the peripheral blood monocytes/macrophages from SIV-infected monkeys. J Neurovirol (1996) 0.80
Enhancement by antisense oligonucleotides to NF-kappaB of the differentiation of HL-60 promyelocytic leukemia cells induced by vitamin D3. Cancer Lett (1998) 0.80
Use of electroporation for high-molecular-weight DNA-mediated gene transfer. Exp Cell Res (1987) 0.80
Altered epidermal growth factor signal transduction in activated Ha-ras-transformed human keratinocytes. Biochem Biophys Res Commun (1993) 0.80
HER-2/neu expression in archival non-small cell lung carcinomas using FDA-approved Hercep test. Anticancer Res (2000) 0.80
Quantification of telomerase activity by direct scintillation counting. J Biochem Biophys Methods (1999) 0.79
Histone exchange in chromatin of hydroxyurea-blocked Ehrlich ascites tumour cells. Nature (1980) 0.79
Evaluation of the role of extracellular matrix proteins, polyunsaturated fatty acids and c-myc expression in the inhibition of the serum-free growth of epithelial cells by TGF-beta 1. In Vitro Cell Dev Biol (1990) 0.79
Fluorescent probe studies of mixed micelles of phospholipids and bile salts. Effect of cholesterol incorporation. Biochim Biophys Acta (1980) 0.78
Down-regulation of procollagen alpha1[I]] messenger RNA by titanium particles correlates with nuclear factor kappaB (NF-kappaB) activation and increased rel A and NF-kappaB1 binding to the collagen promoter. J Bone Miner Res (2001) 0.78
Telomerase as a potential molecular target to study G-quartet phosphorothioates. Antisense Nucleic Acid Drug Dev (1996) 0.78
Comparing pairwise and simultaneous joint registrations of decorrelating interval exams using entropic graphs. Inf Process Med Imaging (2007) 0.78
On the quality control of antisense oligonucleotides. Antisense Nucleic Acid Drug Dev (1996) 0.78
Adrenal myelolipoma: A rare lesion of adrenal gland. Indian J Cancer (2016) 0.78
Immunocytochemical localization of the endogenous neuroexcitotoxin quinolinate in human peripheral blood monocytes/macrophages and the effect of human T-cell lymphotropic virus type I infection. Proc Natl Acad Sci U S A (1996) 0.78
Salt-induced structural changes in nucleosomes. Mol Biol Rep (1980) 0.78
Telomeric DNA: marker for human prostate cancer development? Prostate (1998) 0.77
Stromal cells regulate bcl-2 and bax expression in pro-B cells. Exp Hematol (1996) 0.77
Harnessing the power of antisense technology for combination chemotherapy. J Natl Cancer Inst (1997) 0.77
Isolation of short interspersed repetitive DNA sequences present in the regions of initiation of mammalian DNA replication. Eur J Biochem (1984) 0.77
Synthesis and fluorescence properties of a probe for membrane anionic sites. Biochem Biophys Res Commun (1976) 0.77
Use of electroporation to study the cytotoxic effects of fluorodeoxyuridylate in intact cells. Biochem Pharmacol (1987) 0.77
Neovascular changes after pegaptanib in diabetics. Ophthalmology (2007) 0.76
Isolation and cloning of putative mouse DNA replication initiation sites: binding to nuclear protein factors. Nucleic Acids Res (1993) 0.76
Prediction of skin sensitization potential using D-optimal design and GA-kNN classification methods. SAR QSAR Environ Res (2010) 0.76
Development of an assay system for the detection and classification of methotrexate resistance in fresh human leukemic cells. Cancer Res (1986) 0.76
Antisense rel A in Cancer. Methods Mol Med (1996) 0.76
Saphenoperitoneal shunts for patients with intractable ascites associated with chronic liver disease. Br J Surg (1999) 0.75
Feminisation of medical practice. Lancet (1990) 0.75
Functional neurosurgery in psychiatric illnesses. Indian J Psychiatry (1980) 0.75
Accuracy of a rapid carbohydrate oxidation microtube method for identification of nonfermentative gram-negative bacilli. J Clin Microbiol (1982) 0.75
Correspondence. Retina (2009) 0.75
Late laminectomy in traumatic paraplegia. Surg Neurol (1983) 0.75
Comments on 23-gauge versus 20-gauge system for pars plana vitrectomy. Br J Ophthalmol (2009) 0.75
Endurance based personalized fitness planner. Conf Proc IEEE Eng Med Biol Soc (2016) 0.75